Biogen reported $632.8M in Selling and Administration Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.21B 4M
Acadia Pharmaceuticals ACAD:US USD 104.4M 26.29M
Acorda Therapeutics ACOR:US USD 26.25M 3.26M
Amgen AMGN:US USD 1.47B 181M
Bayer BAYN:GR EUR 4.43B 347M
Biogen BIIB:US USD 632.8M 69.5M
Biomarin Pharmaceutical BMRN:US USD 245.74M 28.92M
Bluebird Bio BLUE:US USD 33.4M 3.29M
Bristol Myers Squibb BMY:US USD 2.27B 336M
Eli Lilly And LLY:US USD 1.64B 29M
Esperion Therapeutics ESPR:US USD 24.14M 816K
Gilead Sciences GILD:US USD 2.02B 807M
Intercept Pharmaceuticals ICPT:US USD 55.29M 12.02M
Intra Cellular Therapies ITCI:US USD 94.63M 6.26M
Marinus Pharmaceuticals MRNS:US USD 14.66M 1.27M
Merk MRK:US USD 2.63B 134M
Moderna Inc MRNA:US USD 375M 97M
Neurocrine Biosciences NBIX:US USD 182.9M 3.4M
Novartis NOVN:VX USD 3.7B 295M
Pfizer PFE:US USD 4.87B 1.33B
Ptc Therapeutics PTCT:US USD 92.72M 12.6M
Puma Biotechnology PBYI:US USD 25.04M 1.08M
Regeneron Pharmaceuticals REGN:US USD 660.5M 131.4M
Sangamo Biosciences SGMO:US USD 16.44M 205K
Sarepta Therapeutics SRPT:US USD 120.48M 15.69M
Seattle Genetics SGEN:US USD 216.1M 5.72M
Teva Pharmaceutical TEVA:IT USD 837M 60M
Ultragenyx Pharmaceutical RARE:US USD 72.85M 3.01M
United Therapeutics UTHR:US USD 152M 53.6M
Vertex Pharmaceuticals VRTX:US USD 267.4M 20.6M
YTE INCY:US USD 272.82M 6.36M